Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
Novavax sees royalties, reduced expenses on COVID vaccines from Sanofi partnership
Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
Novavax Inc (NASDAQ:NVAX) reported fourth-quarter 2024 sales of $88.31 million, compared to $291 million a year, beating the ...
Novavax execs lay out 2025 game plan, talk ‘defining moment’ for business
Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.
Novavax reports large quarterly revenue declines, rethinks its strategic direction
Novavax reported $88 million in revenues in the fourth quarter, compared to $291 million the year prior, and $682 million for ...
Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
COVID-like bat virus discovered by researchers in Chinese lab
Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells ...
Novavax initiated with a Buy at BTIG
BTIG initiated coverage of Novavax (NVAX) with a Buy rating and $19 price target The company’s standalone COVID vaccine seems to be a ...
PhilSTAR Life on MSN6d
Chinese Team Find Bat Virus Enters Human Cells Via Same Pathway As Covid
Bloomberg, which reported on the study earlier on Friday, said the paper identifying the bat virus had moved shares of COVID ...
New bat coronavirus with ‘concerning’ traits found by Chinese researchers
Virologists warn the pathogen should be monitored ‘very, very carefully’ because it attacks human cells in the same way as ...
NVAX Earnings: Novavax Stock Jumps Despite Mixed Q4 Results
Novavax (NVAX) stock jumped today following the release of the vaccine maker’s Q4 2024 earnings report. That follows its diluted earnings per ...
AOL2d
Novavax reports large quarterly revenue declines, rethinks its strategic direction
Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a vaccine maker. The COVID-19 vaccine company, based in Maryland ...